Chemical Structure : CK-101
CAS No.: 1660963-42-7
货号: PC-61597Not For Human Use, Lab Use Only.
CK-101 (Olafertinib, RX-518) is a novel potent, mutant-selective, irreversible, orally available EGFR inhibitor, overcomes T790M-mediated resistance in NSCLC.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥2280 | In stock | |
25 mg | ¥4280 | In stock | |
50 mg | ¥7280 | In stock | |
100 mg | ¥12800 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CK-101 (Olafertinib, RX-518) is a novel potent, mutant-selective, irreversible, orally available EGFR inhibitor, overcomes T790M-mediated resistance in NSCLC.
CK-101 (Olafertinib, RX-518) specifically targets the mutant forms of EGFR, including T790M, while exhibiting minimal activity toward WT EGFR.
CK-101 (Olafertinib, RX-518) selectively inhibits cell proliferation of cell lines expressing both the activating (HCC827, IC50 <15 nM) and resistance mutations (NCI-H1975, IC50 <5 nM).
CK-101 (Olafertinib, RX-518) significantly inhibits tumor growth in EGFR-mutated NSCLC tumor xenograft models, with no activity in WT EGFR tumor xenograft model.
分子量 | 530.58 | |
分子式 | C29H28F2N6O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-[3-[2-[2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]anilino]quinazolin-8-yl]phenyl]prop-2-enamide |
1. Xiangping Qian, et al. Abstract 2078: CK-101 (RX518), a mutant-selective inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC. DOI: 10.1158/1538-7445.AM2017-2078
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright